Corbus Pharmaceuticals announces annual stockholders meeting notice

Reuters04-03
Corbus Pharmaceuticals announces annual stockholders meeting notice
  • Corbus Pharmaceuticals scheduled annual stockholder meeting for May 13, 2026, to be held online.
  • Shareholders will vote on election of six directors to serve until next annual meeting.
  • Ballot includes amendment to 2024 Equity Compensation Plan to raise authorized shares by 3,000,000 to 5,000,000.
  • Items also include ratification of EisnerAmper as independent auditor for fiscal 2026.
  • Advisory votes will cover executive compensation plus preferred frequency for future say-on-pay votes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corbus Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-140363), on April 02, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment